A Comparison of the <svg style="vertical-align:-0.216pt;width:15.0125px;" id="M1" height="10.725" version="1.1" viewBox="0 0 15.0125 10.725" width="15.0125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.725)">
		<g transform="translate(72,-63.42)">
			<text transform="matrix(1,0,0,-1,-71.95,63.68)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg>2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain

<table>GABA<sub>A</sub> receptor occupancy of (a) L-838,417 and (b) TPA023 in whole rat brain compared to drug concentrations in the plasma (nM free). Each datapoint represents an individual animal.</table>

Advances in Pharmacological and Pharmaceutical Sciences

fig1

Figure 1

Figure 1: A Comparison of the <svg style="vertical-align:-0.216pt;width:15.0125px;" id="M1" height="10.725" version="1.1" viewBox="0 0 15.0125 10.725" width="15.0125"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.725)">
		<g transform="translate(72,-63.42)">
			<text transform="matrix(1,0,0,-1,-71.95,63.68)">
				<tspan style="font-size: 17.93px; " x="0" y="0">𝜶</tspan>
			</text>

		</g>
	</g>
</svg>2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain 

Figure 1 | A Comparison of the 
	
		
			
				𝜶
			

		
	
2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain 

Advances in Pharmacological and Pharmaceutical Sciences

A Comparison of the 𝜶 2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain

Figure 1

A Comparison of the 2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain